Quick Takeaways
- ORBIMED ADVISORS LLC filed SCHEDULE 13D/A for Adicet Bio, Inc. Common Stock, par value $0.0001 (ACET).
- Disclosed ownership: 9.6%.
- Date of event: 08 Oct 2025.
Quoteable Key Fact
"ORBIMED ADVISORS LLC disclosed 9.6% ownership in Adicet Bio, Inc. Common Stock, par value $0.0001 (ACET) on 08 Oct 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 9.6% | 14,772,598 | 0 | 14,772,598 | /s/ Carl L. Gordon | Carl L. Gordon / Member | 0001055951 |
| ORBIMED CAPITAL GP VI LLC | 2.9% | 4,490,254 | 0 | 4,490,254 | /s/ Carl L. Gordon | Carl L. Gordon / Member of OrbiMed Advisors LLC | 0001682115 |
| ORBIMED CAPITAL GP V LLC | 5.9% | 9,026,359 | 0 | 9,026,359 | /s/ Carl L. Gordon | Carl L. Gordon / Member of OrbiMed Advisors LLC | 0001615374 |
| OrbiMed Genesis GP LLC | 0.8% | 1,255,985 | 0 | 1,255,985 | /s/ Carl L. Gordon | Carl L. Gordon / Member of OrbiMed Advisors LLC | 0001808744 |
| ORBIMED ADVISORS ISRAEL II LTD | 0.4% | 646,657 | 0 | 646,657 | /s/ Carl L. Gordon | Carl L. Gordon / Director | 0001682093 |
| ORBIMED ISRAEL GP II, L.P. | 0.4% | 646,657 | 0 | 646,657 | /s/ Carl L. Gordon | Carl L. Gordon / Director of OrbiMed Advisors Israel II Limited | 0001682090 |
| ORBIMED ISRAEL GP LTD. | 0.7% | 1,027,885 | 0 | 1,027,885 | /s/ Carl L. Gordon | Carl L. Gordon / Director | 0001569590 |
| ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | 0.7% | 1,027,885 | 0 | 1,027,885 | /s/ Carl L. Gordon | Carl L. Gordon / Director of OrbiMed Israel GP Ltd. | 0001569821 |